Thank you

This live web event has ended. Thank you for attending.

Description

A Pathologist Perspective on
Detecting Targetable EGFR Mutations,
Including Exon 20 Insertions

Why should you register now for this webinar?
Hear a national thought leader discuss detecting targetable EGFR mutations,
including Exon 20 insertions
Brought to you by: CAP TODAY
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Presenter: Shirley Michelle Shiller, DO, MSPT

What will this webinar empower you to do?
Understand the evolving role of EGFR mutations in NSCLC
Examine the detection of targetable EGFR mutations
Learn about Exon 20 insertions
Ask questions of our distinguished presenter

CAP TODAY does not endorse any of the products or services named within.
This webinar is sponsored by Takeda Oncology.